Is Verona Pharma PLC halal to invest in?

As of July 2026, Verona Pharma PLC VRNA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Verona Pharma PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Verona Pharma PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Verona Pharma PLC?

Muslim investors may consider investing in Verona Pharma PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Verona Pharma PLC classified as HALAL?

Musaffa determines the Shariah status of Verona Pharma PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Verona Pharma PLC updated?

The Shariah compliance status of Verona Pharma PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Verona Pharma PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Verona Pharma PLC?

You can check the latest Shariah compliance status of Verona Pharma PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Verona Pharma PLC VRNA

Last Updated: Oct 06, 12:00 AM·BE

VRNA Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Verona Pharma PLC is classified as halal.

HALAL

Report Source: 2025 2nd Quarter Report

Verona Pharma PLC. Stock Analysis VRNA

Germany Health Care Mid Cap Report: Q2, 2025

Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. The firm is focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine, is an investigational, inhaled, small molecule and dual inhibitor of the enzyme’s phosphodiesterase 3 and 4 (PDE3 and PDE4) combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. The company is engaged in developing inhaled ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The firm's two additional formulations of ensifentrine are in Phase II development for the treatment of COPD: dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). The firm's wholly owned subsidiary is Verona Pharma, Inc.

Key Statistics of Verona Pharma PLC (VRNA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€106.81€106.93

Today's Open

€106.85

Volume

1.87M

P/E Ratio (TTM)

52 Week Range

€104.71€106.93

Market Cap

5.53B

Avg. Volume

1.51M

Dividend Yield

Financial Metrics & Statements of Verona Pharma PLC (VRNA)

Super Investors Invested in Verona Pharma PLC (VRNA)

FAQ's for Verona Pharma PLC (VRNA)

As of July 2026, Verona Pharma PLC VRNA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Verona Pharma PLC using these criteria to determine its compliance status.
Muslim investors may consider investing in Verona Pharma PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Verona Pharma PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Verona Pharma PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Verona Pharma PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.